Literature DB >> 1306114

The novel bilirubin/phenol UDP-glucuronosyltransferase UGT1 gene locus: implications for multiple nonhemolytic familial hyperbilirubinemia phenotypes.

I S Owens1, J K Ritter.   

Abstract

At least three types of congenital nonhemolytic unconjugated hyperbilirubinemias, including the rare Crigler-Najjar (CN) diseases (Types I or II) and Gilbert's syndrome (affecting 6% of the population) are associated with either absent or reduced hepatic UDP-glucuronosyltransferase (transferase) activity towards the potentially toxic endogenous acceptor, bilirubin. Here, we review the biochemical studies associated with these deficiencies. Accumulated evidence from studies with an animal model of CN Type I syndrome, the Gunn strain of hyperbilirubinemic rats, suggested that multiple isozymes are absent. These confounding observations have been clarified by a flurry of reports which have revealed the molecular basis for the complex disease phenotype in the Gunn rat and by the isolation and description of a novel human gene complex, UGT1, which encodes multiple and independently-regulated transferase isozymes that contain identical carboxyl terminal regions (246 amino acids). Finally, we discuss the implications of the gene organization and genetic defects determined for four different CN Type I individuals as a basis for a model which explains the inheritance pattern and genotypes of other familial unconjugated hyperbilirubinemias.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1306114     DOI: 10.1097/00008571-199206000-00001

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  15 in total

Review 1.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase.

Authors:  G Jedlitschky; A J Cassidy; M Sales; N Pratt; B Burchell
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

3.  The novel UGT1 gene complex links bilirubin, xenobiotics, and therapeutic drug metabolism by encoding UDP-glucuronosyltransferase isozymes with a common carboxyl terminus.

Authors:  I S Owens; J K Ritter; M T Yeatman; F Chen
Journal:  J Pharmacokinet Biopharm       Date:  1996-10

4.  High-throughput single-base mismatch detection for genotyping of UDP-glucuronosyltransferase (UGT1A1) with probe capture assay coupled with modified allele-specific primer extension reaction (MASPER).

Authors:  Osamu Kisaki; Seiji Kato; Kohei Shinohara; Hisahide Hiura; Tomohiro Samori; Hiroshi Sato
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 5.  Molecular basis of polymorphic drug metabolism.

Authors:  A K Daly
Journal:  J Mol Med (Berl)       Date:  1995-11       Impact factor: 4.599

Review 6.  Pharmacogenetic phenotyping and genotyping. Present status and future potential.

Authors:  F J Gonzalez; J R Idle
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

7.  Effects of thyroid status and thyrostatic drugs on hepatic glucuronidation of lodothyronines and other substrates in rats : Induction of phenol UDP-glucuronyltransferase by methimazole.

Authors:  T J Visser; E Kaptein; A Gijzel; W W de Herder; M L Cannon; F Bonthuis; W J de Greef
Journal:  Endocrine       Date:  1996-02       Impact factor: 3.633

8.  Crigler-Najjar syndrome type II. New observation of possible autosomal recessive inheritance.

Authors:  S Güldütuna; U Langenbeck; K W Bock; A Sieg; U Leuschner
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

9.  Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases.

Authors:  P Labrune; A Myara; M Hadchouel; F Ronchi; O Bernard; F Trivin; N R Chowdhury; J R Chowdhury; A Munnich; M Odièvre
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

10.  Regulation of sulfotransferase and UDP-glucuronosyltransferase gene expression by the PPARs.

Authors:  Melissa Runge-Morris; Thomas A Kocarek
Journal:  PPAR Res       Date:  2009-08-10       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.